A Clinical Update on MASLD

Grace Y Zhang; Danielle Brandman

doi:10.1001/jamainternmed.2024.6431

A Clinical Update on MASLD

JAMA Intern Med. 2025 Jan 1;185(1):105-107. doi: 10.1001/jamainternmed.2024.6431.

Authors

Grace Y Zhang¹, Danielle Brandman²

Affiliations

¹ Division of General Internal Medicine, University of California, San Francisco.
² Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, New York.

PMID: 39585671
DOI: 10.1001/jamainternmed.2024.6431

No abstract available

Plain language summary

This Clinical Insights discusses new diagnostic criteria, risk stratification, and emerging treatments of metabolic dysfunction–associated steatotic liver disease (MASLD; formerly nonalcoholic fatty liver disease).